{"transactions":[{"id":1023522,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-06T18:31:06.000Z","date":"2025-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15255,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 2, 2025, NH Holdings 2025, Inc. (\"Buyer\"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Buyer (\"Merger Sub\"), dated as of December 23, 2024 (the \"Merger Agreement\"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the \"Merger\"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Rollover Agreement, dated as of December 23, 2024 (the \"Rollover Agreement\"), entered into by and among NH Holdings 2025 SPV, L.P. (\"Holdings\"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock (\"Series A Preferred Stock\") and Series B Convertible Perpetual Preferred Stock (\"Series B Preferred Stock\") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the \"Effective Time\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-25-044381","document":"wk-form4_1759789863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000162828025044381/wk-form4_1759789863.xml","form_type":"4"}},{"id":1023521,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-06T18:31:06.000Z","date":"2025-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":250690,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 2, 2025, NH Holdings 2025, Inc. (\"Buyer\"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Buyer (\"Merger Sub\"), dated as of December 23, 2024 (the \"Merger Agreement\"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the \"Merger\"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Rollover Agreement, dated as of December 23, 2024 (the \"Rollover Agreement\"), entered into by and among NH Holdings 2025 SPV, L.P. (\"Holdings\"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock (\"Series A Preferred Stock\") and Series B Convertible Perpetual Preferred Stock (\"Series B Preferred Stock\") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the \"Effective Time\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-25-044381","document":"wk-form4_1759789863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000162828025044381/wk-form4_1759789863.xml","form_type":"4"}},{"id":1147778,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-15T18:20:25.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of these restricted stock units vested on May 13, 2025, one year from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All of these restricted stock units vested on May 13, 2025, one year from the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001628280-25-026099","document":"wk-form4_1747347618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000162828025026099/wk-form4_1747347618.xml","form_type":"4"}},{"id":1147777,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T18:20:25.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15255,"source":{"system":"sec-edgar","filing":"0001628280-25-026099","document":"wk-form4_1747347618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000162828025026099/wk-form4_1747347618.xml","form_type":"4"}},{"id":1517797,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-14T20:41:06.000Z","date":"2024-05-12","kind":"exercise","planned":false,"acquired":false,"shares":4755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of these restricted stock units vested on May 12, 2024, one year from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"All of these restricted stock units vested on May 12, 2024, one year from the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4755},"source":{"system":"sec-edgar","filing":"0001628280-24-023350","document":"wk-form4_1715733654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000162828024023350/wk-form4_1715733654.xml","form_type":"4"}},{"id":1517796,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-14T20:41:06.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of these restricted stock units vest on May 13, 2025, one year from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All of these restricted stock units vest on May 13, 2025, one year from the grant date."}],"balance_after":10500,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001628280-24-023350","document":"wk-form4_1715733654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000162828024023350/wk-form4_1715733654.xml","form_type":"4"}},{"id":1517795,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T20:41:06.000Z","date":"2024-05-12","kind":"exercise","planned":false,"acquired":true,"shares":4755,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4755,"source":{"system":"sec-edgar","filing":"0001628280-24-023350","document":"wk-form4_1715733654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000162828024023350/wk-form4_1715733654.xml","form_type":"4"}},{"id":1891852,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-16T20:18:38.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":380434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the restricted stock units vest on May 12, 2024, one year from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All of the restricted stock units vest on May 12, 2024, one year from the grant date."}],"balance_after":380434,"derivative":{"underlying":"Common Stock","underlying_shares":380434},"source":{"system":"sec-edgar","filing":"0001628280-23-018524","document":"wf-form4_168428270488431.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000162828023018524/wf-form4_168428270488431.xml","form_type":"4"}},{"id":2650534,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Series B Preferred Stock","published_at":"2021-06-30T21:50:26.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":173705,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":521115},"source":{"system":"sec-edgar","filing":"0001415889-21-003305","document":"form4-06302021_090602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003305/form4-06302021_090602.xml","form_type":"4"}},{"id":2650533,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Series A Preferred Stock","published_at":"2021-06-30T21:50:26.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":1226677,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":832604},"source":{"system":"sec-edgar","filing":"0001415889-21-003305","document":"form4-06302021_090602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003305/form4-06302021_090602.xml","form_type":"4"}},{"id":2650532,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Series A Preferred Stock","published_at":"2021-06-30T21:50:26.000Z","date":"2021-05-06","kind":"gift","acquired":true,"shares":248115,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":1226677,"derivative":{"underlying":"Common Stock","underlying_shares":168407},"source":{"system":"sec-edgar","filing":"0001415889-21-003305","document":"form4-06302021_090602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003305/form4-06302021_090602.xml","form_type":"4"}},{"id":2650531,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Series A Preferred Stock","published_at":"2021-06-30T21:50:26.000Z","date":"2021-05-06","kind":"gift","acquired":false,"shares":248115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":168407},"source":{"system":"sec-edgar","filing":"0001415889-21-003305","document":"form4-06302021_090602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003305/form4-06302021_090602.xml","form_type":"4"}},{"id":2650530,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:26.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":521115,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":20055236,"source":{"system":"sec-edgar","filing":"0001415889-21-003305","document":"form4-06302021_090602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003305/form4-06302021_090602.xml","form_type":"4"}},{"id":2650529,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:26.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":832604,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":19534121,"source":{"system":"sec-edgar","filing":"0001415889-21-003305","document":"form4-06302021_090602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003305/form4-06302021_090602.xml","form_type":"4"}},{"id":2650528,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:26.000Z","date":"2021-05-06","kind":"gift","acquired":true,"shares":15765831,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":18701517,"source":{"system":"sec-edgar","filing":"0001415889-21-003305","document":"form4-06302021_090602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003305/form4-06302021_090602.xml","form_type":"4"}},{"id":2650527,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:26.000Z","date":"2021-05-06","kind":"gift","acquired":false,"shares":15765831,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-21-003305","document":"form4-06302021_090602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003305/form4-06302021_090602.xml","form_type":"4"}},{"id":2650542,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Series B Preferred Stock","published_at":"2021-06-30T21:50:22.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":173705,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":521115},"source":{"system":"sec-edgar","filing":"0001415889-21-003304","document":"form4-06302021_090602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003304/form4-06302021_090602.xml","form_type":"4"}},{"id":2650541,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Series A Preferred Stock","published_at":"2021-06-30T21:50:22.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":1226677,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":832604},"source":{"system":"sec-edgar","filing":"0001415889-21-003304","document":"form4-06302021_090602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003304/form4-06302021_090602.xml","form_type":"4"}},{"id":2650540,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Series A Preferred Stock","published_at":"2021-06-30T21:50:22.000Z","date":"2021-05-06","kind":"gift","acquired":true,"shares":248115,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":1226677,"derivative":{"underlying":"Common Stock","underlying_shares":168407},"source":{"system":"sec-edgar","filing":"0001415889-21-003304","document":"form4-06302021_090602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003304/form4-06302021_090602.xml","form_type":"4"}},{"id":2650539,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Series A Preferred Stock","published_at":"2021-06-30T21:50:22.000Z","date":"2021-05-06","kind":"gift","acquired":false,"shares":248115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":168407},"source":{"system":"sec-edgar","filing":"0001415889-21-003304","document":"form4-06302021_090602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003304/form4-06302021_090602.xml","form_type":"4"}},{"id":2650538,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:22.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":521115,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series B Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":20055236,"source":{"system":"sec-edgar","filing":"0001415889-21-003304","document":"form4-06302021_090602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003304/form4-06302021_090602.xml","form_type":"4"}},{"id":2650537,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:22.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":832604,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":19534121,"source":{"system":"sec-edgar","filing":"0001415889-21-003304","document":"form4-06302021_090602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003304/form4-06302021_090602.xml","form_type":"4"}},{"id":2650536,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:22.000Z","date":"2021-05-06","kind":"gift","acquired":true,"shares":15765831,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Robert J. Sheehy Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person is trustee."}],"balance_after":18701517,"source":{"system":"sec-edgar","filing":"0001415889-21-003304","document":"form4-06302021_090602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003304/form4-06302021_090602.xml","form_type":"4"}},{"id":2650535,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"Sheehy Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN OF THE BOARD"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:22.000Z","date":"2021-05-06","kind":"gift","acquired":false,"shares":15765831,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-21-003304","document":"form4-06302021_090602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179978/000141588921003304/form4-06302021_090602.xml","form_type":"4"}},{"id":255357,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":200000,"derivative":{"expiration_date":"2012-08-05","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255356,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":20.535,"expiration_date":"2012-08-05","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255355,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":300000,"derivative":{"expiration_date":"2012-01-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255354,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":17.3875,"expiration_date":"2012-01-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255353,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":300000,"derivative":{"expiration_date":"2011-01-17","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255352,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":13.1719,"expiration_date":"2011-01-17","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255351,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":160000,"derivative":{"expiration_date":"2010-07-26","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255350,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":9.7735,"expiration_date":"2010-07-26","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255349,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":320000,"derivative":{"expiration_date":"2010-03-08","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255348,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":5.9532,"expiration_date":"2010-03-08","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255347,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":310080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":310080,"derivative":{"expiration_date":"2009-10-13","underlying":"Common Stock","underlying_shares":310080},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255346,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":310080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":5.0157,"expiration_date":"2009-10-13","underlying":"Common Stock","underlying_shares":310080},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255345,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":60000,"derivative":{"expiration_date":"2008-10-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255344,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":5,"expiration_date":"2008-10-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255343,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":40000,"derivative":{"expiration_date":"2008-10-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":255342,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:29:31.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\"). In addition, the  exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued to footnote 2)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":4.1719,"expiration_date":"2008-10-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001181431-06-062888","document":"rrd135943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062888/rrd135943.xml","form_type":"4"}},{"id":272333,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2005-11-02T23:25:49.000Z","date":"2005-10-31","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":57.89,"exercise_date":"2006-10-31","expiration_date":"2015-10-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000731766-05-000134","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000134/edgardoc.xml","form_type":"4"}},{"id":279491,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2005-05-04T21:25:45.000Z","date":"2005-05-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable in four equal annual installments beginning May 2, 2006."}],"balance_after":50000,"derivative":{"exercise_price":94.68,"exercise_date":"2006-05-02","expiration_date":"2015-05-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000731766-05-000074","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000074/edgardoc.xml","form_type":"4"}},{"id":279736,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2005-04-29T20:27:47.000Z","date":"2005-04-29","kind":"exercise","acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable as follows: 20,000 shares on 2/16/99; 15,000 shares on each of August 1, 2001, August 1, 2002, August 1, 2003, and February 6, 2004."}],"balance_after":0,"derivative":{"exercise_price":13.0625,"expiration_date":"2008-02-06","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000731766-05-000057","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000057/edgardoc.xml","form_type":"4"}},{"id":279735,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2005-04-29T20:27:47.000Z","date":"2005-04-29","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Performance-based grant vested over 3 year period on annual review of performance guidelines."}],"balance_after":30000,"derivative":{"exercise_price":10,"expiration_date":"2008-10-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000731766-05-000057","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000057/edgardoc.xml","form_type":"4"}},{"id":279734,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2005-04-29T20:27:47.000Z","date":"2005-04-29","kind":"sale","acquired":false,"shares":140000,"price":93.0595,"value":13028330.0,"ownership":{"direct":true},"balance_after":3009,"source":{"system":"sec-edgar","filing":"0000731766-05-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000057/edgardoc.xml","form_type":"4"}},{"id":279733,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2005-04-29T20:27:47.000Z","date":"2005-04-29","kind":"exercise","acquired":true,"shares":80000,"price":13.0625,"value":1045000.0,"ownership":{"direct":true},"balance_after":143009,"source":{"system":"sec-edgar","filing":"0000731766-05-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000057/edgardoc.xml","form_type":"4"}},{"id":279732,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2005-04-29T20:27:47.000Z","date":"2005-04-29","kind":"exercise","acquired":true,"shares":60000,"price":10,"value":600000.0,"ownership":{"direct":true},"balance_after":63009,"source":{"system":"sec-edgar","filing":"0000731766-05-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000057/edgardoc.xml","form_type":"4"}},{"id":284074,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2004-12-09T21:52:31.000Z","date":"2004-12-07","kind":"grant","acquired":true,"shares":103000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable in four equal annual installments beginning 12/7/05."}],"balance_after":103000,"derivative":{"exercise_price":79.7,"expiration_date":"2014-12-07","underlying":"Common Stock","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0000731766-04-000202","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000202/edgardoc.xml","form_type":"4"}},{"id":286333,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2004-09-23T20:51:47.000Z","date":"2004-09-22","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":10.875,"exercise_date":"1998-02-10","expiration_date":"2007-01-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000731766-04-000122","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000122/edgardoc.xml","form_type":"4"}},{"id":286332,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2004-09-23T20:51:47.000Z","date":"2004-09-22","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":10.7657,"exercise_date":"1998-02-10","expiration_date":"2007-10-27","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000731766-04-000122","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000122/edgardoc.xml","form_type":"4"}},{"id":286331,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2004-09-23T20:51:47.000Z","date":"2004-09-22","kind":"sale","acquired":false,"shares":90000,"price":70.5086,"value":6345774.0,"ownership":{"direct":true},"balance_after":2833,"source":{"system":"sec-edgar","filing":"0000731766-04-000122","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000122/edgardoc.xml","form_type":"4"}},{"id":286330,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2004-09-23T20:51:47.000Z","date":"2004-09-22","kind":"exercise","acquired":true,"shares":40000,"price":10.7657,"value":430628.0,"ownership":{"direct":true},"balance_after":92833,"source":{"system":"sec-edgar","filing":"0000731766-04-000122","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000122/edgardoc.xml","form_type":"4"}},{"id":286329,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2004-09-23T20:51:47.000Z","date":"2004-09-22","kind":"exercise","acquired":true,"shares":50000,"price":10.875,"value":543750.0,"ownership":{"direct":true},"balance_after":52833,"source":{"system":"sec-edgar","filing":"0000731766-04-000122","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000122/edgardoc.xml","form_type":"4"}},{"id":297242,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2003-12-23T14:46:49.000Z","date":"2003-12-19","kind":"other","acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Because this is the disposition of a derivative security, sale price does not apply."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance-based grant vested over 3 year period on annual review of performance guidelines."}],"balance_after":90000,"derivative":{"exercise_price":10,"expiration_date":"2008-10-16","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000731766-03-000033","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000033/edgardoc.xml","form_type":"4"}},{"id":297241,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2003-12-23T14:46:49.000Z","date":"2003-12-19","kind":"sale","acquired":false,"shares":150000,"price":56.1452,"value":8421780.0,"ownership":{"direct":true},"balance_after":2380,"source":{"system":"sec-edgar","filing":"0000731766-03-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000033/edgardoc.xml","form_type":"4"}},{"id":297240,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2003-12-23T14:46:49.000Z","date":"2003-12-19","kind":"other","acquired":true,"shares":150000,"price":10,"value":1500000.0,"ownership":{"direct":true},"balance_after":152380,"source":{"system":"sec-edgar","filing":"0000731766-03-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000033/edgardoc.xml","form_type":"4"}},{"id":297799,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2003-12-02T19:54:04.000Z","date":"2003-11-28","kind":"other","acquired":true,"shares":50000,"price":53.9,"value":2695000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable in four equal annual installments beginning 11/28/04."}],"balance_after":50000,"derivative":{"exercise_price":53.9,"exercise_date":"2004-11-28","expiration_date":"2013-11-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000731766-03-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000014/edgardoc.xml","form_type":"4"}},{"id":305248,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Non-Qualified Stock Option","published_at":"2003-05-20T13:58:35.000Z","date":"2003-05-16","kind":"exercise","acquired":false,"shares":30000,"price":500625,"value":15018750000.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":16.6875,"exercise_date":"2003-05-16","expiration_date":"2008-10-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-03-004911","document":"bmn76918_bmn9-rjs.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103004911/bmn76918_bmn9-rjs.xml","form_type":"4"}},{"id":305247,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2003-05-20T13:58:35.000Z","date":"2003-05-16","kind":"sale","acquired":false,"shares":30000,"price":95.4125,"value":2862375.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"290 shares held indirectly by 401(k) account"}],"balance_after":1024,"source":{"system":"sec-edgar","filing":"0001209191-03-004911","document":"bmn76918_bmn9-rjs.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103004911/bmn76918_bmn9-rjs.xml","form_type":"4"}},{"id":305246,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13612,"kind":"person","name":"Sheehy Robert J","position":1,"cik":"0001179978","reported_name":"SHEEHY ROBERT J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2003-05-20T13:58:35.000Z","date":"2003-05-16","kind":"exercise","acquired":true,"shares":30000,"price":16.6875,"value":500625.0,"ownership":{"direct":true},"balance_after":31024,"source":{"system":"sec-edgar","filing":"0001209191-03-004911","document":"bmn76918_bmn9-rjs.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103004911/bmn76918_bmn9-rjs.xml","form_type":"4"}}]}